Literature DB >> 21221677

Contribution of the sclerostin domain-containing protein 1 (SOSTDC1) gene to normal variation of peak bone mineral density in Chinese women and men.

Jin-Wei He1, Hua Yue, Wei-Wei Hu, Yun-Qiu Hu, Zhen-Lin Zhang.   

Abstract

A genome-wide linkage analysis in Chinese families revealed a significant quantitative trait loci on chromosome 7p21.1 for femoral neck bone mineral density (BMD) (LOD = 3.68), and a potential candidate gene, sclerostin domain-containing protein 1 (SOSTDC1), is located in this region. SOSTDC1 belongs to a class of bone morphogenetic protein (BMP) antagonists that bind BMPs and regulate their signaling. We therefore genotyped 6 tag single nucleotide polymorphisms (tag-SNPs) in SOSTDC1 gene using allele-specific PCR method and investigated the association between SOSTDC1 gene polymorphisms and peak BMD variation in 401 Chinese female-offspring nuclear families (including 1260 subjects) and 400 Chinese male-offspring nuclear families (including 1215 subjects), respectively. Using both family-based (quantitative transmission disequilibrium test) and population-based (ANOVA) methods of analyses, BMD values were adjusted for age, height and weight. In female-offspring nuclear families, we found a significant within family association between rs16878759 and the lumbar spine peak BMD (P = 0.003) and rs16878759 accounted for 1.4% of the lumbar spine peak BMD variation. Moreover, haplotype CCC (containing rs12699800, rs16878759, and rs17619769) had a significant within family association with the lumbar spine peak BMD (P = 0.001) and accounted for 1.9% of the peak BMD variation at this bone site. However, in the male-offspring nuclear families, we failed to detect any significant association between any SNP or haplotype and peak BMD at any bone site. In conclusion, our results indicate for the first time that the genetic polymorphisms in SOSTDC1 have an effect on attainment and maintenance of peak bone mass in Chinese women.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21221677     DOI: 10.1007/s00774-010-0253-5

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  40 in total

1.  Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer.

Authors:  Sholom Wacholder; Nathaniel Rothman; Neil Caporaso
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-06       Impact factor: 4.254

2.  Large-scale genome-wide linkage analysis for loci linked to BMD at different skeletal sites in extreme selected sibships.

Authors:  Yi-Hsiang Hsu; Xin Xu; Henry A Terwedow; Tianhua Niu; Xuimei Hong; Di Wu; Lihua Wang; Joseph D Brain; Mary L Bouxsein; Steve R Cummings; Cliff J Rosen; Xiping Xu
Journal:  J Bone Miner Res       Date:  2007-02       Impact factor: 6.741

Review 3.  The TDT and other family-based tests for linkage disequilibrium and association.

Authors:  R S Spielman; W J Ewens
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

4.  Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity.

Authors:  Naoki Kusu; Johanna Laurikkala; Mayumi Imanishi; Hiroko Usui; Morichika Konishi; Ayumi Miyake; Irma Thesleff; Nobuyuki Itoh
Journal:  J Biol Chem       Date:  2003-04-17       Impact factor: 5.157

5.  Sex-specific and non-sex-specific quantitative trait loci contribute to normal variation in bone mineral density in men.

Authors:  Munro Peacock; Daniel L Koller; Tonya Fishburn; Subha Krishnan; Dongbing Lai; Siu Hui; C Conrad Johnston; Tatiana Foroud; Michael J Econs
Journal:  J Clin Endocrinol Metab       Date:  2005-03-01       Impact factor: 5.958

6.  Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS study.

Authors:  Stuart H Ralston; Nick Galwey; Ian MacKay; Omar M E Albagha; Lon Cardon; Juliet E Compston; Cyrus Cooper; Emma Duncan; Richard Keen; Bente Langdahl; Alastair McLellan; Jeffrey O'Riordan; Huibert A Pols; David M Reid; Andre G Uitterlinden; John Wass; Simon T Bennett
Journal:  Hum Mol Genet       Date:  2005-03-03       Impact factor: 6.150

7.  Genetic dissection of mouse distal chromosome 1 reveals three linked BMD QTLs with sex-dependent regulation of bone phenotypes.

Authors:  Wesley G Beamer; Kathryn L Shultz; Cheryl L Ackert-Bicknell; Lindsay G Horton; Krista M Delahunty; Harold F Coombs; Leah R Donahue; Ernesto Canalis; Clifford J Rosen
Journal:  J Bone Miner Res       Date:  2007-08       Impact factor: 6.741

8.  Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians.

Authors:  Shan-Shan Dong; Xiao-Gang Liu; Yuan Chen; Yan Guo; Liang Wang; Jian Zhao; Dong-Hai Xiong; Xiang-Hong Xu; Robert R Recker; Hong-Wen Deng
Journal:  Calcif Tissue Int       Date:  2009-05-21       Impact factor: 4.333

9.  USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney.

Authors:  Motoko Yanagita; Masako Oka; Tetsuro Watabe; Haruhisa Iguchi; Atsushi Niida; Satoru Takahashi; Tetsu Akiyama; Kohei Miyazono; Masashi Yanagisawa; Takeshi Sakurai
Journal:  Biochem Biophys Res Commun       Date:  2004-04-02       Impact factor: 3.575

10.  Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength.

Authors:  Xiaodong Li; Michael S Ominsky; Qing-Tian Niu; Ning Sun; Betsy Daugherty; Diane D'Agostin; Carole Kurahara; Yongming Gao; Jin Cao; Jianhua Gong; Frank Asuncion; Mauricio Barrero; Kelly Warmington; Denise Dwyer; Marina Stolina; Sean Morony; Ildiko Sarosi; Paul J Kostenuik; David L Lacey; W Scott Simonet; Hua Zhu Ke; Chris Paszty
Journal:  J Bone Miner Res       Date:  2008-06       Impact factor: 6.741

View more
  11 in total

Review 1.  Update on Wnt signaling in bone cell biology and bone disease.

Authors:  David G Monroe; Meghan E McGee-Lawrence; Merry Jo Oursler; Jennifer J Westendorf
Journal:  Gene       Date:  2011-11-03       Impact factor: 3.688

2.  Effects of estrogen on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in postmenopausal women.

Authors:  Koji Fujita; Matthew M Roforth; Susan Demaray; Ulrike McGregor; Salman Kirmani; Louise K McCready; James M Peterson; Matthew T Drake; David G Monroe; Sundeep Khosla
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

3.  Sostdc1 deficiency accelerates fracture healing by promoting the expansion of periosteal mesenchymal stem cells.

Authors:  Nicole M Collette; Cristal S Yee; Nicholas R Hum; Deepa K Murugesh; Blaine A Christiansen; LiQin Xie; Aris N Economides; Jennifer O Manilay; Alexander G Robling; Gabriela G Loots
Journal:  Bone       Date:  2016-04-19       Impact factor: 4.398

4.  Estrogen receptor α in osteocytes regulates trabecular bone formation in female mice.

Authors:  Shino Kondoh; Kazuki Inoue; Katsuhide Igarashi; Hiroe Sugizaki; Yuko Shirode-Fukuda; Erina Inoue; Taiyong Yu; Jun K Takeuchi; Jun Kanno; Lynda F Bonewald; Yuuki Imai
Journal:  Bone       Date:  2013-12-10       Impact factor: 4.398

5.  GREB1 genetic variants are associated with bone mineral density in Caucasians.

Authors:  Kevin G Hegarty; Frances J Drummond; Mary Daly; Fergus Shanahan; Michael G Molloy
Journal:  J Bone Miner Metab       Date:  2017-03-14       Impact factor: 2.626

6.  Polymorphisms in the human ALOX12 and ALOX15 genes are associated with peak bone mineral density in Chinese nuclear families.

Authors:  W-J Xiao; Y-H Ke; J-W He; H Zhang; J-B Yu; W-W Hu; J-M Gu; G Gao; H Yue; C Wang; Y-Q Hu; M Li; Y-J Liu; W-Z Fu; Z-L Zhang
Journal:  Osteoporos Int       Date:  2011-11-17       Impact factor: 4.507

Review 7.  Clinical utility of serum sclerostin measurements.

Authors:  Bart L Clarke; Matthew T Drake
Journal:  Bonekey Rep       Date:  2013-06-05

8.  Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans.

Authors:  Matthew M Roforth; Koji Fujita; Ulrike I McGregor; Salman Kirmani; Louise K McCready; James M Peterson; Matthew T Drake; David G Monroe; Sundeep Khosla
Journal:  Bone       Date:  2013-10-29       Impact factor: 4.398

Review 9.  Genetic polymorphism in extracellular regulators of Wnt signaling pathway.

Authors:  Garima Sharma; Ashish Ranjan Sharma; Eun-Min Seo; Ju-Suk Nam
Journal:  Biomed Res Int       Date:  2015-04-05       Impact factor: 3.411

Review 10.  Genome-wide approaches for identifying genetic risk factors for osteoporosis.

Authors:  Shuyan Wu; Yongjun Liu; Lei Zhang; Yingying Han; Yong Lin; Hong-Wen Deng
Journal:  Genome Med       Date:  2013-05-29       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.